Phase I/II trial of neoadjuvant chemoradiotherapy with 5-FU, cisplatin, mitomycin C, and heparin for borderline resectable pancreatic cancer.
Taizo Hibi
No relevant relationships to disclose
Minoru Kitago
No relevant relationships to disclose
Koichi Aiura
No relevant relationships to disclose
Minoru Tanabe
No relevant relationships to disclose
Osamu Itano
No relevant relationships to disclose
Masahiro Shinoda
No relevant relationships to disclose
Yuta Abe
No relevant relationships to disclose
Hiroshi Yagi
No relevant relationships to disclose
Yuko Kitagawa
No relevant relationships to disclose